Weidle, U.H.* ; Dickopf, S.* ; Hintermair, C. ; Kollmorgen, G.* ; Birzele, F.* ; Brinkmann, U.*
The role of micro RNAs in breast cancer metastasis: Preclinical Validation and potential therapeutic targets.
Cancer Genomics Proteomics 15, 17-39 (2018)
Despite the approval of several molecular therapies in the last years, breast cancer-associated death ranks as the second highest in women. This is due to metastatic disease, which represents a challenge for treatment. A better understanding of the molecular mechanisms of metastasis is, therefore, of paramount importance. In this review we summarize the role of micro RNAs (miRs) involved in metastasis of breast cancer. We present an overview on metastasis-promoting, -suppressing and context-dependent miRs with both activities. We have categorized the corresponding miRs according to their target classes, interaction with stromal cells or exosomes. The pathways affected by individual miRs are outlined in regard to in vitro properties, activity in metastasis-related in vivo models and clinical significance. Current approaches that may be suitable for therapeutic inhibition or restauration of miR activity are outlined. Finally, we discuss the delivery bottlenecks which present as a major challenge in nucleic acid (miR)-based therapies.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Review
Thesis type
Editors
Keywords
Colonization Of Distinct Organs ; Epithelial-mesenchymal Transition (emt) ; Exosomes ; Mesenchymal-epithelial Transition (met) ; Metastasis-related In Vivo Models ; Migration And Invasion ; Review ; Tumor Cell/stromal Cell Interactions
Keywords plus
Language
Publication Year
2018
Prepublished in Year
2017
HGF-reported in Year
2017
ISSN (print) / ISBN
1109-6535
e-ISSN
1790-6245
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 15,
Issue: 1,
Pages: 17-39
Article Number: ,
Supplement: ,
Series
Publisher
International Institute of Anticancer Research
Publishing Place
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502890-001
Grants
Copyright
Erfassungsdatum
2018-01-24